Income StatementBalance SheetCash FlowSegments
AbbVie logo

AbbVie Balance Sheet Statement

Assets, liabilities, and shareholders' equity

AbbVie holds $136.46B in total assets. Cash and equivalents total $9.4B. The current ratio is 0.796. Based on the Q1 2026 filing.

Total Assets$136.46BTotal Stockholders Equity-$6.7BLong Term Debt$58.9BCash And Equivalents$9.4BTotal Current Assets$33.5BTotal Current Liabilities$42.1B
Latest FilingQ1 2026
Report Date2026-05-08
Market Cap$369.98B
P/E Ratio101.78
ROE-139.97%

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$10.9B$12.5B$12.6B$12.8B$12.6B$12.5B
Cash and cash equivalents$5.5B$5.2B$6.5B$5.6B$5.2B$9.4B
Finished goods————$1.6B$1.8B
Prepaid expenses and other————$6.3B$6.6B
Raw materials$1.1B$1.1B$1.2B$1.1B$1.1B$1.1B
Work in process$2.0B$2.0B$2.1B$2.3B$2.3B$2.1B
Inventories$4.2B$4.5B$5.0B$4.9B$5.0B$5.0B
Total current assets$25.6B$27.7B$29.3B$28.5B$29.1B$33.5B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accumulated other comprehensive income (loss)-$1.9B-$1.7B-$1.5B-$1.6B-$1.1B-$1.2B
Common stock$18.0M$18.0M$18.0M$18.0M$18.0M$18.0M
Additional paid-in capital————$22.5B$23.0B
Treasury Stock, Value————$9.1B$10.6B
Retained earnings-$7.9B-$9.5B-$11.5B-$14.2B-$15.5B-$17.9B
Total liabilities and stockholders' equity$135.2B$136.2B$137.2B$133.9B$134.0B$136.5B
Total stockholders' equity$3.3B$1.5B-$138.0M-$2.6B-$3.3B-$6.7B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
AOCI - Cash Flow Hedge Reclassification (Next 12 Months)—$105.0M-$8.0M-$36.0M—$1.0M
Common stock, par value (in dollars per share)————$0.01$0.01
Common stock, shares authorized (in shares)————4B4B
Common stock, shares issued (in shares)————1.8B1.8B
Deferred income taxes————$2.4B$2.3B
Derivative, gross, assets————$91.0M$155.0M
Derivatives, gross, liabilities————$540.0M$338.0M
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value$21.7B$22.7B——$25.4B$27.0B
Finite-Lived Intangible Assets, Accumulated Amortization————$42.2B$43.9B
Gross Carrying Amount————$89.6B$89.5B
Indefinite- lived intangible impairment————$94.9B$94.8B
Estimated litigation liability————$1.6B$1.7B
Long-Term Debt and Lease Obligation————$58.9B$64.5B
Noncontrolling interests in subsidiaries————$42.0M$44.0M
Share Repurchase Program, Remaining Authorized, Amount—————$1.8B
Pre-tax gains (losses) to be transferred into interest expense, net for treasury rate lock agreement cash flow hedges during the next 12 months—————$23.0M
Treasury stock, shares (in shares)————70.8M77.1M

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable and other current liabilities (Note 11)————$34.7B$33.8B
Current portion of long-term debt$6.8B$3.8B$2.0B$2.0B$6.1B$0.0
Current Portion of Long-Term Debt and Finance Lease Obligations————$6.1B$8.3B
Finance Lease Liability, Current$17.0M———$19.0M—
Short-term borrowings$0.0$1.6B$5.6B$3.8B$2.5B$0.0
Total current liabilities$38.7B$36.4B$39.8B$39.4B$43.3B$42.1B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments————$159.0M$163.0M
Goodwill$35.0B$35.3B$35.6B$35.6B$35.6B$35.6B
Indefinite-Lived Intangible Assets————$5.3B$5.3B
Intangible assets — net————$47.4B$45.6B
Other intangible assets—net————$52.6B$50.9B
Investments————$268.0M$268.0M
Other non-current assets————$10.7B$10.5B
Property, plant and equipment at cost————$13.5B$13.7B
Accumulated depreciation$7.1B$36.8B$38.8B$40.4B$7.9B$8.0B
Property and equipment, net$5.1B$12.6B$12.9B$13.2B$5.6B$5.7B
Total assets$135.2B$136.2B$137.2B$133.9B$134.0B$136.5B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-current liabilities$30.1B$31.2B$32.0B$31.7B$32.6B$34.1B